European Nuclear Medicine Guide
|
AA |
Alzheimer Association |
|
AP |
Angina Pectoris |
|
ACD |
Acid Citrate Dextrose |
|
AD |
Alzheimer’s Disease |
|
AMP |
Adenosine monophosphate |
|
ARSAC |
UK Administration of Radioactive Substances Advisory Committee |
|
AUC |
Appropriate Use Criteria |
|
AV |
Atrioventricular Block |
|
BBB |
Blood Brain Barrier |
|
BD |
Brain Death |
|
CAD |
Coronary Artery Disease |
|
CI |
Confidence Interval |
|
CIT |
Carbomethoxy-3 β-(4-Iodophenyltropane |
|
CBD |
Corticobasal syndrome |
|
COPD |
Chronic Obstructive Pulmonary Disease |
|
CMRgl |
Cerebral Metabolic Rate of glucose consumption |
|
CT |
Computed Tomography |
|
DaT |
Dopamine Transporters |
|
DLB |
Dementia with Lewes Bodies |
|
DRF |
Differential Renal Function |
|
ECG |
Electrocardiogram |
|
ED |
Effective Dose |
|
EDV |
End Diastolic Volume |
|
EF |
Ejection Fraction |
|
EMA |
European Medicines Agency |
|
ERPF |
Effective Renal Plasma Flow |
|
ERNA |
Equilibrium Radionuclide Angiocardiography |
|
ESV |
End Systolic Volume |
|
ECD |
Ethyl Cysteine Dimer |
|
EMA |
European Medicine Agency |
|
ETS |
Oesophageal Transit Scintigraphy |
|
FCH |
18F-fluorocholine |
|
FDA |
Food and Drug Administration |
|
FDG |
Fluorodeoxyglucose |
|
FDOPA |
6-fluoro-[18F]-L-DOPA |
|
FLT |
18F-fluoro-L-thymidine |
|
FPB |
Filtered Back Projection |
|
FPRNV |
First-Pass Radionuclide Ventriculography |
|
FTD |
Frontotemporal dementia |
|
FUO |
Fever of Unknown Origin |
|
GBEF |
Gall Bladder Ejection Factor |
|
GCPII |
Glutamate Carboxypeptidase II |
|
GEP |
Gastro-Entero-Pancreatic |
|
GER |
Gastro-Oesophageal Reflux |
|
GFR |
Glomerular Filtration Rate |
|
ERPF |
Effective Renal Plasma Flow |
|
GIBS |
Gastrointestinal Bleeding Scintigraphy |
|
GLUT |
Glucose Transporters |
|
HDRBC |
Heat Damaged Red Blood Cells |
|
HGG |
High Grade Glioma |
|
HIDA |
Hepatobiliary Iminodiacetic Acid |
|
HMPAO |
Hexamethyl Propylene Amine Oxime |
|
HOCM |
Hypertrophic Obstructive Cardiomyopathy |
|
HPT |
Hypothalamo-Pituitary-Thyroid |
|
HSA |
Human Serum Albumin |
|
ICA |
Invasive Coronary Angiography |
|
ICRP |
International Commission on Radiation Protection |
|
LBBB |
Left Bundle Branch Block |
|
LEHR |
Low-energy High-Resolution |
|
LEUHR |
Low-energy Ultra High-Resolution |
|
LGG |
Low Grade Glioma |
|
LOA |
Left Oblique Orientation |
|
L/R |
Lesion to Reference ratio |
|
LV |
Left Ventricle |
|
LVEF |
Left Ventricular Ejection Factor |
|
MACE |
Major Adverse Cardiac Event |
|
MCI |
Mild Cognitive Impairment |
|
MET |
Methionine |
|
MI |
Myocardial Infarction |
|
MLEM |
Maximum-likelihood Expectation Maximization |
|
MPI |
Myocardial Perfusion Imaging |
|
MRI |
Magnetic Resonance Imaging |
|
MPS |
Myocardial Perfusion Scintigraphy |
|
MSA |
Multiple System Atrophy |
|
NEN |
Neuroendocrine Neoplasms |
|
NET |
Human Endocrine Tumours |
|
NIS |
Sodium/Iodide Symporter |
|
NPO |
Nil Per Oral |
|
OSEM |
Ordered Subset Expectation Maximization |
|
PAH |
Para-Aminohippuric acid |
|
PE |
Pulmonary Embolism |
|
PET |
Positron Emission Tomography |
|
PIOPED |
Prospective Investigation of Pulmonary Embolism Diagnosis |
|
PSMA |
Prostate Specific Membrane Antigen |
|
PSP |
Progressive Supranuclear Palsy |
|
RBC |
Red Blood Cells |
|
RES |
Reticuloendothelial System |
|
ROA |
Right Oblique Orientation |
|
ROI |
Region of Interest |
|
RPF |
Renal Plasma Flow |
|
RV |
Right Ventricle |
|
SDHD |
Succinate Dehydrogenase subunit D |
|
SLN |
Sentinel Lymph Node |
|
SLNB |
Sentinel Lymph Node Biopsy |
|
SDS |
Summed Difference Score |
|
SNMMI |
Society of Nuclear Medicine and Molecular Imaging |
|
SOD |
Sphincter of Oddi Dysfunction |
|
SPECT |
Single-Photon Emission Computed Tomography |
|
SSS |
Summed Stress Score |
|
SSTR |
Somatostatin Receptor |
|
SRF |
Split Renal Function |
|
SUV |
Standardized Uptake Value |
|
TAC |
Time Activity Curve |
|
TBR |
Tumour to Background Ratio |
|
TSH |
Thyroid Stimulating Hormone |
|
VCUG |
Voiding Cystourethrography |
|
V/Q |
Ventilation and perfusion |
|
VUR |
Vesico-Ureteral Reflux |
|
WBC |
White Blood Cells |